Drug recall · October 26, 2022
Flunisolide Nasal Solution recall
Why: Out of specification for related substances (impurities).
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408; NDC 50742-317-25 UPC 3 50742 31725 7
- Lots / codes
Lot #: 22E040 Exp. 07/2023; 22F038 Exp. 08/2023
- Quantity
- 6176 bottles
- Company
- Ingenus Pharmaceuticals Llc, Orlando, FL
- Distribution
- Nationwide within the United States
- Initiated
- September 30, 2022 · Voluntary: Firm initiated
- Classified
- October 17, 2022
- Reported
- October 26, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Flunisolide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.